Small Pharma Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
George Tziras
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 1.3yrs |
| Board average tenure | 2.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 31 2023 | n/a | n/a | -CA$19m |
| May 31 2023 | n/a | n/a | -CA$23m |
| Feb 28 2023 | n/a | n/a | -CA$23m |
| Nov 30 2022 | n/a | n/a | -CA$25m |
| Aug 31 2022 | n/a | n/a | -CA$23m |
| May 31 2022 | n/a | n/a | -CA$20m |
| Feb 28 2022 | CA$403k | CA$337k | -CA$22m |
| Nov 30 2021 | n/a | n/a | -CA$21m |
| Aug 31 2021 | n/a | n/a | -CA$18m |
| May 31 2021 | n/a | n/a | -CA$15m |
| Feb 28 2021 | CA$66k | CA$66k | -CA$7m |
Compensation vs Market: Insufficient data to establish whether George's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: George's compensation has increased whilst the company is unprofitable.
CEO
George Tziras
1.3yrs
Tenure
CA$402,552
Compensation
Mr. George Tziras serevs as Chief Business Officer & Director at Cybin Inc. since October 2023. He served as Chief Business Officer of Small Pharma Inc. since January 2021 until July 2022 and also serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Non-Independent Director | 1.3yrs | CA$402.55k | no data | |
| Chief Financial Officer | 2.8yrs | CA$392.92k | 0% CA$ 0 | |
| Chief Scientific & Medical Officer | 3.3yrs | CA$491.59k | no data | |
| Chief Manufacturing & Development Officer & Director | 1.3yrs | CA$464.44k | 0% CA$ 0 | |
| Chief Operating Officer | 1.3yrs | no data | 0% CA$ 0 | |
| Head of Brand & Communications | 1.1yrs | no data | no data | |
| Head of Intellectual Property | 2.8yrs | no data | no data | |
| Corporate Secretary | no data | no data | no data | |
| Group Financial Controller | 1.3yrs | no data | no data | |
| Director of Development and Member of Scientific & Advisory Board | 7.4yrs | no data | no data |
1.3yrs
Average Tenure
56yo
Average Age
Experienced Management: DMT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Non-Independent Director | 2.5yrs | CA$402.55k | no data | |
| Chief Manufacturing & Development Officer & Director | 2.5yrs | CA$464.44k | 0% CA$ 0 | |
| Director of Development and Member of Scientific & Advisory Board | 6.3yrs | no data | no data | |
| Non-Executive Independent Director | 1.9yrs | CA$21.43k | no data | |
| Independent Director | 2.5yrs | CA$62.98k | 0% CA$ 0 | |
| Non-Executive Independent Chairman | 2.5yrs | CA$93.96k | 0% CA$ 0 | |
| Member of Scientific & Advisory Board | 6.3yrs | no data | no data | |
| Member of Scientific & Advisory Board | 6.3yrs | no data | no data |
2.5yrs
Average Tenure
60yo
Average Age
Experienced Board: DMT's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.